The total return over the past 12 months is -5.53% vs. +16.94% for the S&P 500. So far it's up -3.04% this year. Includes price appreciation + reinvested dividends.
| Category | 1Y (TTM) | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Price CAGR | (5.52%) | +5.92% | (26.46%) | (29.45%) | (33.50%) | (24.73%) |
| Total Return CAGR | (5.53%) | +5.92% | (26.46%) | (29.45%) | (33.50%) | (24.73%) |
| Revenue CAGR | N/A | +92.64% | (10.26%) | +38.99% | +28.77% | N/A |
| Net Income CAGR | (209.86%) | N/A | N/A | N/A | N/A | N/A |
| EPS CAGR | (217.03%) | N/A | N/A | N/A | N/A | N/A |
| Free Cash Flow CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| Operating Cash Flow CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| Dividends CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
Visualize historical growth rates over rolling horizons. Use the dropdown to select different metric vectors.
Abeona Therapeutics Inc. (ABEO)
| Year | Start price | End price | ABEO Return | SPY Return | Outperformance |
|---|---|---|---|---|---|
| 2026(YTD) | $5.27 | $5.11 | (3.04%) | +14.51% | (17.55%) |
| 2025 | $5.57 | $5.27 | (5.39%) | +17.72% | (23.11%) |
| 2024 | $5.01 | $5.57 | +11.18% | +24.89% | (13.71%) |
| 2023 | $3.08 | $5.01 | +62.64% | +26.19% | +36.45% |
| 2022 | $8.50 | $3.08 | (63.75%) | (18.17%) | (45.58%) |
| 2021 | $39.25 | $8.50 | (78.35%) | +28.74% | (107.09%) |
| 2020 | $81.75 | $39.25 | (51.99%) | +18.37% | (70.36%) |
| 2019 | $178.50 | $81.75 | (54.20%) | +31.22% | (85.42%) |
| 2018 | $396.25 | $178.50 | (54.95%) | (4.56%) | (50.39%) |
| 2017 | $121.25 | $396.25 | +226.80% | +21.70% | +205.10% |
Start and end prices are split-adjusted closing prices. Total return includes reinvested dividends, so it can differ from the price change.
